AllQuantitative Report
logoArgusMarch 31, 2021

XNCR: Lowering target price to $45.00

Symbols
XNCR
Sector(s)
Healthcare
Rating
Current Price
$39.61
Price Target
$NaN
Earnings Estimate
Summary

Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases with unmet medical needs.

Subscribe to Yahoo Finance Plus Essential for full access
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
Try it Free